This article is part of Co-Occurring Disorders & Dual Diagnosis in Addiction Care, a clinical series focused on how mental health conditions and substance use disorders intersect—and why treating both is essential for recovery.
More than 7 million Americans live with both a substance use disorder and a mental health disorder.
This isn’t the exception — it’s the norm.
As Psychiatric Mental Health Nurse Practitioners (PMHNPs), we see daily how untreated psychiatric conditions fuel substance use. Patients often tell us:
- “I drink so I can sleep.”
- “I use stimulants because my ADHD was never treated.”
- “Opioids are the only thing that quiets my anxiety.”
- “Cannabis helps me keep the trauma memories away.”
These are not moral failures.
They are attempts at regulation.
Addiction and mental illness rarely exist separately — and effective recovery requires treating both at the same time.
This article explains how PMHNPs identify and treat co-occurring disorders, and why this approach is foundational to sustainable addiction recovery.
Why Co-Occurring Disorders When underlying psychiatric conditions remain untreated:
- Cravings intensify
- Relapse risk increases
- Emotional regulation deteriorates
- Shame and self-blame deepen
- Trauma symptoms escalate
- Motivation collapses
- Neurobiology remains destabilized
Treating substance use alone — without addressing mental health — often leads to revolving-door recovery.
A core PMHNP responsibility is to diagnose and treat co-occurring disorders simultaneously, not sequentially.
How PMHNPs Build Effective Treatment Plans
PMHNPs integrate multiple layers of care, including:
- Medications to reduce cravings
- Psychiatric medications to stabilize mood, anxiety, attention, or trauma
- Therapy for emotional regulation and insight
- Harm-reduction strategies
- Relapse-prevention planning
- Lifestyle stabilization (sleep, routines, nutrition)
Equally important, PMHNPs avoid high-risk prescribing, including:
- Benzodiazepines outside of withdrawal protocols
- Stimulants without thorough assessment
- Sedative-hypnotics with misuse potential
- High-risk sleep medications
Safe, ethical prescribing is central to PMHNP practice.
Why Treating Co-Occurring Disorders Improves Outcomes
Research consistently shows that integrated psychiatric care leads to:
- Up to 40% lower relapse rates
- Longer treatment retention
- Improved emotional regulation
- Reduced cravings
- Better quality of life
- Improved long-term recovery stability
Addiction recovery is not just behavioral — it is psychiatric and neurobiological.
PMHNPs play a critical role in bridging these domains.
Common Co-Occurring Disorders PMHNPs Identify
ADHD
ADHD is frequently undiagnosed or misdiagnosed in adults with substance use disorders.
Patients may self-medicate with:
- Alcohol
- Cannabis
- Stimulants
- Opioids
- Nicotine
PMHNPs assess:
- Childhood symptom patterns
- Executive functioning deficits
- Impulsivity vs. intoxication
- Trauma overlap
When appropriate, PMHNPs determine if and how stimulant or non-stimulant treatment can be used safely, minimizing misuse risk while improving functioning.
Depression
Depression is a powerful driver of relapse.
PMHNPs assess:
- Hopelessness
- Anhedonia
- Suicidal ideation
- Low motivation
- Sleep disruption
Treatment often includes:
Stabilizing mood reduces relapse vulnerability.
Anxiety Disorders
Many patients report that anxiety preceded substance use.
PMHNPs evaluate for:
- Generalized anxiety disorder
- Panic disorder
- Somatic anxiety
- Trauma-related anxiety
Treatment focuses on non-addictive medication options, therapy integration, and nervous-system regulation — avoiding benzodiazepine dependence outside of acute withdrawal contexts.
PTSD & Trauma-Related Disorders
Trauma is one of the strongest predictors of addiction.
PMHNPs assess for:
- Dissociation
- Nightmares
- Flashbacks
- Hypervigilance
- Avoidance
- Emotional numbing
Trauma-informed psychiatric care ensures that substances are no longer needed to survive symptoms.
Bipolar Disorder
Undiagnosed bipolar disorder significantly increases substance use risk.
PMHNPs assess:
- Mood cycling
- Sleep disruption
- Impulsivity
- Energy fluctuations
- Antidepressant reactions
Mood stabilization is essential before long-term recovery is possible.
The PMHNP Role in Sustainable Recovery
Co-occurring disorders are not barriers to recovery — they are the treatment roadmap.
When PMHNPs address both addiction and mental health together:
- Patients feel understood
- Shame decreases
- Treatment engagement improves
- Recovery becomes sustainable
Effective addiction care requires psychiatric expertise — and PMHNPs are uniquely positioned to provide it.
Co-occurring disorders refer to the presence of both a substance use disorder and one or more mental health conditions, such as depression, anxiety, ADHD, PTSD, or bipolar disorder.
Untreated mental health conditions increase cravings, relapse risk, and emotional instability. PMHNPs are trained to treat both conditions simultaneously for better outcomes.
Yes. Untreated ADHD can lead individuals to self-medicate with substances. Proper psychiatric assessment and treatment can significantly reduce misuse risk.
PMHNPs use evidence-based medications, avoid high-risk prescribing, integrate therapy, and apply harm-reduction principles to support recovery.
Yes. Integrated treatment of co-occurring disorders is associated with lower relapse rates, longer treatment engagement, and improved quality of life